Literature DB >> 12462973

The role of structural and functional homology between human apolipoprotein A-I and envelope proteins of human immunodeficiency virus type 1 in CD4 receptor binding.

L E Panin1, N E Kostina, V A Lukashev.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12462973     DOI: 10.1023/a:1019963423498

Source DB:  PubMed          Journal:  Dokl Biochem Biophys        ISSN: 1607-6729            Impact factor:   0.788


× No keyword cloud information.
  6 in total

1.  Detection of circulating p24 antigen-positive CD4+ cells during HIV infection by flow cytometry.

Authors:  P Costigliola; F Tumietto; E Ricchi; F Chiodo
Journal:  AIDS       Date:  1992-10       Impact factor: 4.177

2.  The isolation and nucleotide sequence of a cDNA encoding the T cell surface protein T4: a new member of the immunoglobulin gene family.

Authors:  P J Maddon; D R Littman; M Godfrey; D E Maddon; L Chess; R Axel
Journal:  Cell       Date:  1985-08       Impact factor: 41.582

3.  [Effect of spatial coupling of amino acid residues on the possibility of mutational substitution in globular proteins].

Authors:  V A Lukashev; A G Bachinskiĭ; V A Kulichkov
Journal:  Mol Biol (Mosk)       Date:  1986 Sep-Oct

4.  Apolipoprotein A-1 interacts with the N-terminal fusogenic domains of SIV (simian immunodeficiency virus) GP32 and HIV (human immunodeficiency virus) GP41: implications in viral entry.

Authors:  I Martin; M C Dubois; T Saermark; J M Ruysschaert
Journal:  Biochem Biophys Res Commun       Date:  1992-07-15       Impact factor: 3.575

5.  Apolipoprotein A-I and its amphipathic helix peptide analogues inhibit human immunodeficiency virus-induced syncytium formation.

Authors:  B J Owens; G M Anantharamaiah; J B Kahlon; R V Srinivas; R W Compans; J P Segrest
Journal:  J Clin Invest       Date:  1990-10       Impact factor: 14.808

6.  Evidence by peptide mapping that the region CD4(81-92) is involved in gp120/CD4 interaction leading to HIV infection and HIV-induced syncytium formation.

Authors:  V S Kalyanaraman; D M Rausch; J Osborne; M Padgett; K M Hwang; J D Lifson; L E Eiden
Journal:  J Immunol       Date:  1990-12-15       Impact factor: 5.422

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.